Biblioteca Humberto Rosselli Quijano
Información del autor
Autor L. Alan Sroufe |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs / Deborah B. Jacobvitz en Annual progress in child psychiatry and child develoment, Año 1991 ([10/11/2020])
[artículo]
Título : Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs : a comprehensive review Tipo de documento: texto impreso Autores: Deborah B. Jacobvitz, Autor ; L. Alan Sroufe, Autor ; Mark Stewart, Autor Fecha de publicación: 2020 Artículo en la página: pp. 492-518 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Efectos de excitación, Trastorno por déficit de atención e hiperactividad, Efectos cerebrales, Simpaticomiméticos. Resumen: Issues concerning sympathomimetic drug treatment of children with attentional problems and hyperactivity are considered in light of cumulative and current research. These issues concern the atypical or "paradoxical" drug response of such children, predictability of drug response from neurological or biochemical assessments, and, especially, long-term outcome or effectiveness of sympathomimetic medication. Link: ./index.php?lvl=notice_display&id=25203
in Annual progress in child psychiatry and child develoment > Año 1991 [10/11/2020] . - pp. 492-518[artículo] Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs : a comprehensive review [texto impreso] / Deborah B. Jacobvitz, Autor ; L. Alan Sroufe, Autor ; Mark Stewart, Autor . - 2020 . - pp. 492-518.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Annual progress in child psychiatry and child develoment > Año 1991 [10/11/2020] . - pp. 492-518
Palabras clave: Efectos de excitación, Trastorno por déficit de atención e hiperactividad, Efectos cerebrales, Simpaticomiméticos. Resumen: Issues concerning sympathomimetic drug treatment of children with attentional problems and hyperactivity are considered in light of cumulative and current research. These issues concern the atypical or "paradoxical" drug response of such children, predictability of drug response from neurological or biochemical assessments, and, especially, long-term outcome or effectiveness of sympathomimetic medication. Link: ./index.php?lvl=notice_display&id=25203